Skip to content
HowShorted

Arcturus Therapeutics Holdings Inc. short interest in 2023

In 2023, Arcturus Therapeutics Holdings Inc.'s disclosed short interest ran from 6.29% of shares outstanding on 13 Jan 2023 to 15.44% on 29 Dec 2023, a change of +9.15 percentage points. The year's high was 20.32% on 30 Nov 2023 and its low 6.29% on 13 Jan 2023, averaging 13.48% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.05 days on 13 Oct 2023. Full history: Arcturus Therapeutics Holdings Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Arcturus Therapeutics Holdings Inc. in 2023

2023 in figures

Start of year
6.29% (13 Jan 2023)
End of year
15.44% (29 Dec 2023)
Change
+9.15 pp
High
20.32% (30 Nov 2023)
Low
6.29% (13 Jan 2023)
Average
13.48%
Highest days to cover
18.05 (13 Oct 2023)
SEC filings marked
8

Every report in 2023

Arcturus Therapeutics Holdings Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20236.29%3.97
31 Jan 20236.92%6.42
15 Feb 20238.41%6.27
28 Feb 20238.85%6.75
15 Mar 20239.59%8.21
31 Mar 20239.99%3.24results (8-K), 10-K filed
14 Apr 202310.59%4.45
28 Apr 202311.83%7.55
15 May 202312.50%6.4110-Q filed, results (8-K)
31 May 202313.60%9.85
15 Jun 202313.62%13.10
30 Jun 202312.54%6.53
14 Jul 202313.66%7.32
31 Jul 202314.45%8.92
15 Aug 202314.74%6.7710-Q filed, results (8-K)
31 Aug 202314.79%10.92
15 Sep 202315.77%9.85
29 Sep 202317.32%12.72
13 Oct 202318.02%18.05
31 Oct 202318.75%16.17
15 Nov 202318.95%9.2910-Q filed, results (8-K)
30 Nov 202320.32%12.44
15 Dec 202316.58%9.19
29 Dec 202315.44%10.53

See also: Arcturus Therapeutics Holdings Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.